Pharmagreen Biotech Inc.
PHBI · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -47.4% | -23.1% | 65.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -383.6% | 41.4% | 44.6% | 25.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -14,582.1% | -7,660.8% | -7,420.2% | -10,052.3% |
| Other Income/Exp. Net | $0 | -$0 | $1 | -$1 |
| Pre-Tax Income | $0 | -$0 | $1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | $1 | -$1 |
| % Margin | 13,606.6% | -21,063.7% | 76,484.2% | -155,503.2% |
| EPS | 0 | -0 | 0.001 | -0.001 |
| % Growth | 150% | -120% | 183.3% | – |
| EPS Diluted | 0 | -0 | 0.001 | -0.001 |
| Weighted Avg Shares Out | 664 | 664 | 664 | 664 |
| Weighted Avg Shares Out Dil | 664 | 664 | 664 | 664 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $1 | -$1 |
| % Margin | 16,655.2% | -19,786.8% | 77,488.3% | -153,843.9% |